Wu Shi Yan - Net Worth and Insider Trading
Wu Shi Yan Net Worth
The estimated net worth of Wu Shi Yan is at least $0 dollars as of 2024-06-22. Wu Shi Yan is the Supervisors of Hubei Biocause Pharmaceutical Co Ltd and owns about 0 shares of Hubei Biocause Pharmaceutical Co Ltd (SZSE:000627) stock worth over $0. Details can be seen in Wu Shi Yan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Wu Shi Yan has not made any transactions after 2007-05-28 and currently still holds the listed stock(s).
Transaction Summary of Wu Shi Yan
Wu Shi Yan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wu Shi Yan owns 1 companies in total, including Hubei Biocause Pharmaceutical Co Ltd (SZSE:000627) .
Click here to see the complete history of Wu Shi Yan’s form 4 insider trades.
Insider Ownership Summary of Wu Shi Yan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SZSE:000627 | Hubei Biocause Pharmaceutical Co Ltd | 2007-05-28 | Supervisors |
Wu Shi Yan Latest Holdings Summary
Wu Shi Yan currently owns a total of 1 stock. Wu Shi Yan owns 0 shares of Hubei Biocause Pharmaceutical Co Ltd (SZSE:000627) as of May 28, 2007, with a value of $0.
Latest Holdings of Wu Shi Yan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SZSE:000627 | Hubei Biocause Pharmaceutical Co Ltd | 2007-05-28 | 0 | 1.85 | 0 |
Holding Weightings of Wu Shi Yan
Wu Shi Yan Form 4 Trading Tracker
According to the SEC Form 4 filings, Wu Shi Yan has made a total of 0 transactions in Hubei Biocause Pharmaceutical Co Ltd (SZSE:000627) over the past 5 years. The most-recent trade in Hubei Biocause Pharmaceutical Co Ltd is the acquisition of 14,800 shares on May 28, 2007, which cost Wu Shi Yan around $112,080.
Insider Trading History of Wu Shi Yan
- 1
Wu Shi Yan Trading Performance
GuruFocus tracks the stock performance after each of Wu Shi Yan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wu Shi Yan is -27.14%. GuruFocus also compares Wu Shi Yan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wu Shi Yan within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wu Shi Yan's insider trading performs compared to the benchmark.
Performance of Wu Shi Yan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -44.16 | | | | | |
| Relative Return to S&P 500(%) | -43.5 | | | | | |
Wu Shi Yan Ownership Network
Wu Shi Yan Owned Company Details
What does Hubei Biocause Pharmaceutical Co Ltd do?
Who are the key executives at Hubei Biocause Pharmaceutical Co Ltd?
Wu Shi Yan is the Supervisors of Hubei Biocause Pharmaceutical Co Ltd. Other key executives at Hubei Biocause Pharmaceutical Co Ltd include Independent director Jiang Hai Hua , and Directors & executives Fu Yong Jin .
Hubei Biocause Pharmaceutical Co Ltd (SZSE:000627) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Hubei Biocause Pharmaceutical Co Ltd (SZSE:000627) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Hubei Biocause Pharmaceutical Co Ltd (SZSE:000627) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Hubei Biocause Pharmaceutical Co Ltd (SZSE:000627)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hubei Biocause Pharmaceutical Co Ltd Insider Transactions
Wu Shi Yan Mailing Address
Above is the net worth, insider trading, and ownership report for Wu Shi Yan. Currently GuruFocus does not have mailing address information for Wu Shi Yan.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
